Concepedia
Statistics
Publications
3
Citations
53
H-Index
Active since
2019
Affiliations
Novo Nordisk (Denmark)(Current)
Mads Bjelke is an author at Novo Nordisk (Denmark).
Publications per year
2019–2022
A novel next‐generation FVIIIa mimetic, Mim8, has a favorable safety profile and displays potent pharmacodynamic effects: Results from safety studies in cynomolgus monkeys
Brian Lauritzen, Mads Bjelke, Olle Björkdahl et al. · Journal of Thrombosis and Haemostasis · 2022 · 32 citations · Full text
Absorption, metabolism and excretion of once-weekly somapacitan, a long-acting growth hormone derivative, after single subcutaneous dosing in human subjects
Hans Helleberg, Mads Bjelke, Birgitte Bentz Damholt et al. · European Journal of Pharmaceutical Sciences · 2021 · 11 citations · Full text
Administration of recombinant FVIIa (rFVIIa) to concizumab‐dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits
Brian Lauritzen, Janne Olling, Kristin L. Abel et al. · Journal of Thrombosis and Haemostasis · 2019 · 10 citations
1–3 of 3